$IBIO Balance Sheet | Understand Stock

$IBIO

$0.71 -$0.01 (1.5%) Close

$IBIO Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q4 FY2026 As of Jun 30, 2026	Q3 FY2026 As of Mar 31, 2026	Q2 FY2026 As of Dec 31, 2025	Q1 FY2026 As of Sep 30, 2025	Q4 FY2025 As of Jun 30, 2025	Q3 FY2025 As of Mar 31, 2025	Q2 FY2025 As of Dec 31, 2024	Q1 FY2025 As of Sep 30, 2024	Q4 FY2024 As of Jun 30, 2024	Q3 FY2024 As of Mar 31, 2024	Q2 FY2024 As of Dec 31, 2023	Q1 FY2024 As of Sep 30, 2023	Q4 FY2023 As of Jun 30, 2023	Q3 FY2023 As of Mar 31, 2023	Q2 FY2023 As of Dec 31, 2022	Q1 FY2023 As of Sep 30, 2022	Q4 FY2022 As of Jun 30, 2022	Q3 FY2022 As of Mar 31, 2022	Q2 FY2022 As of Dec 31, 2021	Q1 FY2022 As of Sep 30, 2021
Assets
Current assets:
Cash and cash equivalents
Restricted cash
Settlement receivable - current portion
Accounts receivable - trade, net of allowance for credit losses of $65 and $0 as of June 30, 2026 and June 30, 2025, respectively
Investments in debt securities (adjusted cost $27,156 and $0, respectively - see Note 6)
Inventory
Investments in debt securities (adjusted cost $31,689 and $0 as of June 30, 2026 and June 30, 2025, respectively - see Note 6)
Subscription receivable
Promissory note receivable and accrued interest
Prepaid expenses and other current assets
Current assets held for sale (see Note 3 - Discontinued Operations)
Total Current Assets

Restricted cash
Settlement receivable - noncurrent portion
Promissory note receivable
Promissory note receivable and accrued interest
Finance lease right-of-use assets, net of accumulated amortization
Operating lease right-of-use asset, net of accumulated amortization
Fixed assets, net of accumulated depreciation
Intangible assets, net of accumulated amortization
Investments in equity security - at cost
Prepaid expenses - noncurrent
Noncurrent assets held for sale
Security deposits
Total Assets

Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable
Accrued expenses
Acquisition Payable
Finance lease obligations
Operating lease obligation - current portion
Term promissory note - current portion
Equipment financing payable - current portion
Term promissory note
Insurance premium financing payable
Term note payable - net of deferred financing costs
Contract liabilities
Current liabilities related to assets held for sale
Total Current Liabilities

Finance lease obligations - net of current portion
Operating lease obligation - net of current portion
Accrued expenses - noncurrent
Noncurrent liabilities related to assets held for sale
Equipment financing payable - net of current portion
Term promissory note - net of current portion
Total Liabilities
Equity:
Stockholders' Equity
Preferred Stock - $0.001 par value; 1,000,000 shares authorized; 0 shares issued and outstanding (see Note 16)
Common Stock - $0.001 par value; 275,000,000 shares authorized; 55,698,561 and 19,349,201 shares issued and outstanding as of June 30, 2026 and June 30, 2025, respectively
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Total Stockholders' Equity
Noncontrolling interest
Total Equity

Total Liabilities and Stockholders' Equity

Comments